CYLOC

Serial Number 87242385
602

Registration Progress

Application Filed
Nov 18, 2016
Under Examination
Nov 21, 2017
Approved for Publication
Sep 26, 2017
Published for Opposition
Sep 26, 2017
Registered

Trademark Image

CYLOC

Basic Information

Serial Number
87242385
Filing Date
November 18, 2016
Published for Opposition
September 26, 2017
Abandonment Date
September 24, 2018
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Oct 24, 2018
Classes
001

Rights Holder

Tesseract Medical Research, LLC

16
Address
1370 Trancas Street, Suite 350
Napa, CA 94558

Ownership History

Tesseract Medical Research, LLC

Original Applicant
16
Napa, CA

Tesseract Medical Research, LLC

Owner at Publication
16
Napa, CA

Legal Representation

Attorney
Kim R. Pearson

USPTO Deadlines

All Deadlines Cleared

All 11 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

44 events
Date Code Type Description Documents
Oct 24, 2018 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Oct 24, 2018 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Mar 23, 2018 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Mar 23, 2018 GNRT O NON-FINAL ACTION E-MAILED Loading...
Mar 23, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 9, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 9, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 6, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 23, 2018 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Jan 23, 2018 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jan 23, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 13, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 13, 2018 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Dec 28, 2017 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Dec 28, 2017 IUAF S USE AMENDMENT FILED Loading...
Nov 21, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 26, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 26, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 6, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 21, 2017 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Aug 11, 2017 ALIE A ASSIGNED TO LIE Loading...
Jul 31, 2017 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Jul 31, 2017 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 31, 2017 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jul 31, 2017 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jul 31, 2017 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 31, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 25, 2017 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Jul 6, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 4, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 3, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 3, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 13, 2017 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 13, 2017 GNRT O NON-FINAL ACTION E-MAILED Loading...
Apr 13, 2017 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 3, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 3, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 3, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 22, 2017 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 22, 2017 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 22, 2017 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 21, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 28, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 22, 2016 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Ingredients, namely, fatty acids, enzymes, botanical extracts, minerals, vitamins, and amino acids used in the manufacture of nutritional supplements and in the manufacture of dietary supplements wherein individual molecules of a fatty acid, enzyme, or botanical extract are physically combined with a host molecule to enhance the therapeutic properties of the fatty acid, enzyme, or botanical extract
First Use Anywhere: Jul 17, 2017
First Use in Commerce: Jul 17, 2017

Classification

International Classes
001